Merck & Co. (MRK) is a top pharma stock in the domestic manufacturing boom.
From Yahoo Finance: 2025-05-13 17:06:00
The pharmaceutical industry is experiencing a domestic manufacturing boom, with Merck & Co., Inc. (MRK) among the best pharma stocks to invest in. The U.S. has seen a decline in manufacturing, importing around $203 billion in pharmaceutical products in 2023. President Trump’s executive order aims to incentivize domestic drug manufacturing by streamlining processes and increasing inspections.
The order also directed the EPA to accelerate the construction of drug manufacturing facilities. This move comes ahead of potential tariffs on imported pharmaceuticals, sparking investments from top drugmakers. However, some companies are concerned about the impact on R&D and manufacturing costs. Reshoring manufacturing can strengthen the drug supply chain but may lead to higher prices.
Merck & Co., Inc. (MRK) plans to counter tariff effects by opening a new $1 billion plant in the U.S. by 2030. This strategic decision aligns with the current administration’s goals. The company ranks fourth among the best pharma stocks to invest in. While MRK shows potential, other AI stocks may offer higher returns in a shorter timeframe.
Investing in AI stocks may present more promising opportunities than pharmaceuticals like MRK. Consider exploring AI stocks with significant growth potential. The article provides insights into the best AI stocks to buy now and stocks favored by billionaires for investment opportunities.
Read more at Yahoo Finance: Is Merck & Co. (MRK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?